Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: ZOM stock price vs ACN: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at ACN's multiple
Needs ACN P/S.
Implied fair value · at ZOM's multiple
Needs ZOM P/S.
Metric by metric
Live quote
Price unavailable
Where each company leads, and how wide the gap is.
Growth edge
Pricing power
Operating leverage
Lower is better
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: ZOM FY 2025 (ended Dec 31, 2025) · ACN FY 2025 (ended Aug 31, 2025). Fiscal years are not aligned.
Trendline
Five fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Price framework
Discounted free cash flow, then bridged to a per-share price. Same assumptions applied to both companies.
Zomedica Corp. · implied price per share
Bear
-$0.06
Base
-$0.07
Bull
-$0.08
Accenture plc · implied price per share
Bear
$116.76
Base
$137.36
Bull
$157.97
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Debt / equity
Total debt against shareholders' equity
0.01x
0.17x
Net debt / EBITDA
Leverage against operating earnings
0.11x
-0.53x
Cash and equivalents
Liquid reserves on the balance sheet
$9.02M
$11.48B
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
Zoetis Inc.
ZOM vs ZTS
Elanco Animal Health Inc
ZOM vs ELAN
PHIBRO ANIMAL HEALTH CORP
ZOM vs PAHC
INTERNATIONAL BUSINESS MACHINES CORP
ZOM vs IBM
COGNIZANT TECHNOLOGY SOLUTIONS CORP
ZOM vs CTSH
DXC Technology Co
ZOM vs DXC
Infosys Ltd
ZOM vs INFY
MARSH & MCLENNAN COMPANIES, INC.
ZOM vs MMC
ROBERT HALF INC.
ZOM vs RHI
$1.05M
$5.15B
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.
Live quote
